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Abstract.  PURPOSE. To investigate the anti-
proliferative effect of A. blanchetti and A. schottii 
extracts. METHODS. The anti-proliferative 
effect of  A. blanchetti and A. schottii ethanolic 
extracts on K562 leukemic cells as well as on 
BMEC and HUVEC were evaluated. 
Phytochemical analysis to identify the possible 
active components was carried out. RESULTS. 
The root extract  of A. schottii was the moust 
active of them. At 80 μg/mL, the root extracts 
showed a cytostatic effect on K562, whereas at 
400 μg/mL, there was a strong cytotoxic effect. 
Similar cytostatic and cytotoxic effects were seen 
in the endothelial cells, but at lower doses. The 
effect of A. schottii root extract on endothelial 
cells was seen at concentrations ten times lower 
(8 μg/mL) than the effect of the A. blanchetti root 
extract (80 μg/mL). Phytochemical investigation 
of different fractions and parts of the plant led to 
the isolation of several known compounds, some 
of which are described for the first time in the 
genus Allamanda, and with previous evidence of 
anticancer and antitumoral properties. 
CONCLUSIONS. Our results suggest that both 
plants studied exhibit cytostatic and cytotoxic 
activity, but the most active compounds are 
located in the roots. 
INTRODUCTION   
 
Allamanda (Apocynaceae) is a genus of climbing 
shrubs, which comprises ten species distributed in 
Brazil (1). Some species, including Allamanda 
cathartica, A. blanchetti and A. schottii have been 
analyzed with respect to their chemical 
composition and pharmacological properties. A. 
cathartica L. has long been used in traditional 
medicine for different purposes, including, for 
example, the treatment of liver tumors (2). A. 
blanchetti and A. schottii, are commonly used as 
ornamental plants. 
Previous work has been demonstrated the 
presence of the bioactive iridoid lactones 
plumericin, isoplumericin (3), allamandin (4), 
plumieride (5), plumieride coumarate, and 
plumieride coumarate glucoside (6) on A. 
cathartica. The compounds plumericin, 
isoplumericin and  5.6-dimethoxycoumarin 
(unckalin) were previously isolated from A. 
blanchetti (7), while isoplumericin, plumericin, 
allamandin, allamacin, scopoletin, scoporone and 
pinoresinol were obtained from A. schottii(8). 
Plumericin and isoplumericin exhibited cytotoxic 
activity against Madison lung carcinoma (M109) 
(3). Moreover, fulvoplumierin, another iridoid 
present in plants of the genus Allamanda, 
demonstrated antifungal, antileukemic, 
antimicrobiological and anti-HIV properties 
(9,10). More recently, the anticancer activity of 
plumieride has been demonstrated  (11). 
We are interested in exploring the 
medicinal potential of A. blanchetti and A. 
schottii, grown in Brazil, in terms of their 
cytotoxic activity against leukemia. Since 
leukemia is associated with increased 
angiogenesis in the bone marrow, which is 
thought to promote the survival of leukemia cells, 
we also investigated the antiangiogenic effect of 
Allamanda extracts, by evaluating its cytotoxic 
effects against endothelial cells. In addition, we 
also evaluated the main components present in the 
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MATERIAL AND METHODS 
 
Plant material   
 
The leaves, stems and roots of A. blanchetti and 
A.schottii, were collected in Florianópolis, SC, 
Brazil in February and December, 2002, 
respectively. The plant material was classified by 
Prof. Oscar Benigno Iza (UNIVALI and HBR) 
and samples of the specimens collected were 
deposited at the Barbosa Rodrigues Herbarium 
(HBR, Itajaí), under numbers HBR 52524 and 
52525, respectively.  
 
Preparation of extracts for pharmacological 
assays 
 
The dried vegetal material was extracted 
exhaustively with 95% ethanol at room 
temperature by percolation, for a period of seven 
days. Solvent removal was carried out under 
reduced pressure, until the desired concentrations 
were achieved, in order to obtain the ethanol 
extracts for use in the pharmacological assays. 
 
Isolation and identification of components from 
A. blanchetti 
 
The ethanolic extract from leaves and stems (68.7 
g), which were combined due to their similar 
phytochemical profile by tlc, and roots (98.4 g), 
were successively partitionated with hexane, 
dichloromethane, ethyl acetate and butanol, to 
obtain the respective fractions, after the removal 
of solvents.  
The hexane fraction from the stems and 
leaves (4.70 g) was chromatographed on silica-gel 
column with hexane:EtOAc gradient, giving a 
solid which was successively recrystalized from 
ethyl acetate/methanol to yield a mixture of β-
sitosterol (1) and stigmasterol (2) (14.0 mg). 
The EtOAc fraction (4.90 g) was 
chromatographed on silica-gel column and eluted 
with CHCl3:MeOH gradient, yielding the 
following compounds: 5,7,4’-tri- 
hydroxyisoflavone (3) (10.3 mg) (CHCl3:MeOH 
9:1), kaempferol (4) (26.5 mg), kaempferol-3-O 
β-arabinofuranoside (5) (111.3 mg) 
(CHCl3:MeOH 8.5:1.5) and  quercetin-3-O-
glucose (6) (17.0 mg) (CHCl3:MeOH 8:2).   
The CHCl3 fraction from roots (3.3 g) 
was chromatographed on silica-gel column with 
hexane:EtOAc gradient. The fraction eluted with 
hexane gave plumericin (7) (86.1 mg), whereas 
the elution with hexane:ethyl acetate 8:2 yielded 
p-coumaric acid (8) (64.4 mg).  A fraction called 
204-216, eluted with CHCl3: EtOAc gradient, 
gave eudesmine (9) (10.2 mg).  
 
Isolation and identification of components from 
A. schottii 
 
The ethanolic extract from the aerial parts 
(leaves and stems) of A. schottii (77.6 g) and 
roots (21.2g)  were partitioned with hexane, 
dichloromethane, ethyl acetate and butanol, as in 
the previous case, to give the respective fractions. 
The dichloromethane and ethyl acetate 
fractions of the aerial parts were combined (20.26 
g), since they showed similar chromatographic 
profiles, and chromatographed on silica-gel 
column with dichloromethane: EtOAc: ethanol 
gradient. Fraction 58-75, re-chromatographed as 
in the previous case, and eluted with 
Hexane:DCM gradient yielded, after 
crystallization, a mixture of β-sitosterol (1) and 
stigmasterol (2) (20.0 mg).  Fraction 80-106 
eluted with n-hexane:ethyl acetate 8:2  yielded 
plumericin  (7) (56.3 mg) and scopoletin (10) 
(14.5 mg) when eluted with dichloromethane: 
ethanol 8:2, and ursolic acid (11) (267.8 mg). 
Fraction eluted with dichloromethane: ethanol 6:4 
yielded plumierede (12) (74.3 mg). 
The dichloromethane fraction from roots 
(5.35 g) was chromatographed on silica-gel 
column with hexane:acetone gradient, furnishing 
plumericin (22.1 mg) (7), isoplumericin (18.0 mg) 
(13), 1-(3,4-dimethoxyphenyl)-ethano-1,2-diol 




The ethanolic extracts (root, steam and leaves) of 
A. blanchetti and A. schottii were dissolved at 100 
μg/μL in Dimethylsulfoxide (DMSO) and kept 
frozen. Working solutions at 0.04, 0.4, and 2 
μg/μL, in culture medium were prepared 
immediately prior to use. 
 
Cell Isolation and culture.  
 
Bone marrow endothelial cells (BMEC) were 
isolated from donor bone marrow samples using 
CD105 microbeads (Miltenyi Biotec), according 
to the manufacturer’s specifications.  
 
 

















































































































The CD105 positive cells were cultured in EGM2-
MV medium (Clonetics) at 37°C and 5%CO2. Cells 
with 2 to 5 passages were used in the experiments. 
Human umbilical cord endothelial cells (HUVEC) 
were obtained from Clonetics and cultured in 
EGM2-MV. K-562 cells were obtained from the 
American Type Culture Collection (Manassas, VA) 
and cultured in RPMI 1640 supplemented with 10% 




K-562 cells were plated at 20,000 cells/well in 
RPMI 1640 supplemented with 10% FBS. Cultured 
BMEC or HUVEC were trypsinized, and 3,000 
cells/well plated in 96 well plates with 100 μL 
EGM2-MV medium (Clonetics). After overnight 
incubation, 25 μL of serial plant extract dilutions 
(in RPMI 1640 supplemented with 5% FBS), or 
vehicle (DMSO), were added to each well, in 
triplicate. The final DMSO concentration in assay, 
when using the higher amount of extract, was 0.4%. 
At different incubation times, the number of cells 
and viability were measured by adding 25 μL of 
MTS reagent (Promega). After 1h (for K562) or 3h 
(for BMEC and HUVEC) incubation at 37°C and 
5%CO2, absorbance was measured at 490nm and 
the number of cells was calculated by comparison 
with a standard curve. 
 
RESULTS AND DISCUSSION   
 
In a program to search for Brazilian medicinal 
plants with anticancer properties, we selected two 
plants, A. blanchetti and A. schottii, considering 
some important factors related to the discovery of 
new drugs from the biodiversity: the abundance of 
the plants, their popular use, and previous studies 
(12).  
Thus, the activities of ethanolic extracts 
obtained from different parts of the selected plants 
were assayed on the proliferation and survival of 
the leukemic K562 cell line or primary cultured 
endothelial cells, using the MTS colorimetric assay 
(Promega). As shown in Figures 1 and 2, the 
ethanolic root extracts presented higher cytotoxic 
activity than the ethanolic leaf and stem extracts, in 
all the cells tested. A. schottii  and A. blanchetti root 
extracts showed similar cytostatic (80 μg/mL) and 
cytotoxic (400 μg/mL) effects against K-562 cells. 
In general, endothelial cells were more sensitive to 
Allamanda extracts than K562 cells. Interestingly, 
the effect of A. schottii root extract on endothelial 
cells was seen at  concentrations ten times lower (8 
μg/mL) than the effect of A. blanchetti root extract 
(80 μg/mL). Since the effects of these extracts on 
K562 cells were the same, it is tempting to 
speculate that A. schottii roots contain higher 
amounts of a species-specific anti-angiogenic 
compound. Moreover, it showed a dose-dependent 
effect, and at such low concentrations of crude 
extract, that one may suspect a potent anti-
angiogenic compound. 
Increasing evidence suggests that cancer 
development is associated with angiogenesis (13). 
The formation of new vessels is necessary to 
establish continuity with the systemic circulation 
and nourish the developing tumor (13), and to 
facilitate the spread of the tumor (14, 15). Since 
angiogenesis is critical for tumor development, it 
has been suggested that inhibition of angiogenesis 
may retard tumor growth in humans (13). This has 
led to a redoubled research effort aimed at 
developing anti-angiogenic cancer therapies. 
Several anti-angiogenic agents have been identified 
and produced in recent years (16-21). Angiogenesis 
is a tightly regulated process in which new vascular 
structures are formed from pre-existing vessels 
(14). During angiogenesis, quiescent endothelial 
cells undergo considerable change in their activity, 
including proliferation, migration, and structural 
reorganization, and develop an “invasive” 
phenotype. Our results (Table 1) show that a very 
low concentration of A. schottii root extract inhibits 
at least the proliferation of endothelial cells. Future 
studies are necessary to define its impact on 
endothelial cell migration and morphogenesis. 
 









Figure 1: Cytotoxic activity of A. schottii ethanolic extracts on the in vitro proliferation and survival 
of leukemic and endothelial cells. Ethanolic leaf, stem and root extracts were assayed against three 
different cultured cells: K-562, a cell line derived from Chronic Myeloid Leukemia in blastic crisis; BMEC, 
primary bone marrow endothelial cells; and HUVEC, primary human umbilical cord endothelial cells. The 
number of viable cells was determined after 24h and 48h of culture, by MTS colorimetric assay. ■, control; ○, 
0.4% DMSO; ∆, 8 ug/mL of extract; ∇, 80ug/mL of extract; ◊, 400 ug/mL of extract. Each point represents 












Figure 2: Cytotoxic activity of A. blanchetti ethanolic extracts on the in vitro proliferation and survival 
of leukemic and endothelial cells. See key to Figure 1. 
 
Such promising results prompted us to investigate 
the main components of these plants. Thus, the 
ethanolic extracts from different parts were 
successively partitioned with solvents of 
increasing polarity, such as hexane, 
dichloromethane, ethyl acetate and butanol, 
according to the previously described method 
(12). TLC studies evidenced a similar chemical 
composition in the leaves and stems, and a 
significant difference in the roots, confirmed by 
the biological effects, which were more 
pronounced in the roots.  
The use of conventional chromatographic 
techniques (column chromatography, thin layer 
chromatography) and spectral data (IR, 1H and 
13C-NMR), allows us to determine several 
components, some of which have well-
documented biological properties (see 
experimental part). The spectral data for all the 
compounds were identical to those previously 
reported in the literature.  







Table 1. Amounts (mg) of each compounds isolated from different plant organs and the antiproliferative 
effects on leukemic and endothelial cells. 
A. Amounts of compounds isolated from different plant organs 
  Leaf + Stem Root 







β-sitosterol (1) and stigmasgerol (2) 14.0 20.0 - - 
5,7,4’-tri-hydroxyisoflavone (3) 10.3 - - - 
kaempferol (4) 26.5 - - - 
kaempferol-3-O-β-arabinofuranoside (5) 111.3 - - - 
quercetin-3-O-glucose (6) 17.0 - - - 
scopoletin (10) - 14.5 - - 
ursolic acid (11) - 267.8 - - 
plumieride (12) - 74.3 - - 
plumericin (7) - 56.3 86.1 22.1 
p-coumaric acid (8) - - 64.4 - 
eudesmane (9) - - 10.2 - 
isoplumericin (13) - - - 18.0 
1-(3,4-dimetoxyphenyl)-ethano-1,2-diol (14) - - - 8.3 
Scoparone (15)    15.2 
B. Anti-proliferative effect of crude ethanolic extracts b 
 Leaf extract Stem extract Root extract 
Cell blanchetti schottii blanchetti schottii blanchetti schottii 
K562 400 <400 400* <400 80* 80* 
BMEC >80* <80 80 <80 <80* 8* 
HUVEC >80* 80 80 80 <80* 8* 
a Starting amount of ethanolic crude extracts. See methods for details; b Dose, in μg/mL at which an effect on 
the proliferation was observed; * Cytostatic effect at the dose stated. At higher doses, a cytotoxic effect is 
observed. 
 
Although the compounds isolated from both 
plants are already known, the biological 
properties related to these plants remain obscure. 
In this context, it is important to mention some 
experimental results from the literature, with the 
components, or related structures, present in the 
two species of Allamanda studied here.  Two of 
these, ursolic acid (11) and plumieride (12), are 
well-documented compounds which possess 
important antitumor properties  (11, 22). Several 
flavonoids, specifically some kaempferol 
glycosides, caused cytotoxic activity against 
human leukaemic cell lines in vitro and other 
cancer cells (23,24). Scopoletin (10) was reported 
as an active antitumoral agent from Micromelum 
integerrimum against P-388 lymphocytic 
leukemia system in mice (25). 
To the best of our knowledge, compounds 
5, 6, 8, 9 and 14 are described here for the first 
time in the genus Allamanda, contributing to its 
chemotaxonomy. It is clear from the results that 
the strong citotoxic activity of the A. schottii root 







extract is not due to the presence of plumericin, 
which is present in greater quantity in the roots of 
A. blanchettii. Studies are now in progress to 
verify the compounds responsible for the 
biological effects caused by most active ethanolic 
extracts. 
 
CONCLUSIONS   
 
In summary, our results suggest that both plants 
studied exhibit cytostatic and cytotoxic activity, 
but the most active compounds are located in the 
roots. Further studies are needed to determine 
whether the isolated compound, or other 
compounds not yet isolated, could hold promise 
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